Issue
Title
Authors
No 3 (2019)
Inflationary processes in the pharmaceutical market: development forecasting
Livansky S.M., Utyomova A.S., Denisova M.N.
PDF
(Rus)
No 10 (2019)
Key trends in the mucoactive drugs market
Prozherina Y.
PDF
(Rus)
No 12 (2018)
The role of the clinical pharmacist-in-charge in inter-professional collaboration: a view of specialists from different countries
Chukreeva N.V., Maksimkina E.A.
PDF
(Rus)
No 4 (2019)
PRESCRIPTION DRUG INSURANCE: CHOOSING A PATH
Popovich L.D.
PDF
(Rus)
No 6 (2018)
Pharmaceutical industry for Q I, 2018
Romanova S.
PDF
(Rus)
No 9 (2020)
Comparison and analysis of the fda approved orphane drugs register and the vital and essential drugs list of the Russian Federation
Yurochkin D.S., Leshkevich A.A., Golant Z.M., Narkevich I.A.
PDF
(Rus)
No 1 (2022)
Features of drug provision in palliative care
Volkova N.S.
No 11 (2019)
Construct validation and reliability analysis of a questionnaire to evaluate the factors influencing pharmacy staff's recommendation of over-the-counter drugs in Vietnam
Tran V.D., Dorofeeva V.V., Lagutkina T.P.
PDF
(Rus)
No 12 (2018)
Analysis of patent portfolios of anticancer drugs
Viukhin M., Shulgin V., Bushueva M.
PDF
(Rus)
No 6 (2018)
Rational drug therapy of ulcerative colitis: meta-analysis and clinical and economic aspects of modern therapy regimens
Shatalova O.V., Gorbatenko V.S.
PDF
(Rus)
No 7-8 (2020)
The electronic common technical documentformat as the basis for a single pharmaceutical market of the Eurasian Economic Union
Taube А.А., Levashova A.Y.
PDF
(Rus)
No 4 (2021)
Economic overview of the Russian pharmaceutical market during the pandemic crisis
Bazhenova S.A., Grammova E.A.
No 10 (2019)
Analysis of the Russian paediatric antibacterials market
Narkevich I.A., Nemyatykh O.D., Medvedeva D.M., Ladut'ko Y.M., Terninko T.M., Zagalov D.E., Mikhaylova Y.V.
PDF
(Rus)
No 12 (2018)
Advertising in the pharm market: evaluation of 2018 practice and forecasts for self-regulation
Borzova M.
PDF
(Rus)
No 1-2 (2019)
Changes in VED list: an opportunity that came true
Prozherina J., Shirokova I.
PDF
(Rus)
No 6 (2018)
«May» prospects for Russian pharma market
Trofimova Е.О.
PDF
(Rus)
No 4-6 (2020)
Medical device manufacturing: results of 2019
Romanova S.
PDF
(Rus)
No 4 (2021)
Development of proposals for improving the processes of circulation of extemporal drugs and regulation of prescription and production activities of pharmaceutical organizations in the Russian Federation
Narkevich I.A., Golant Z.M., Yurochkin D.S., Leshkevich A.A., Erdni-Garyaev S.E.
No 11 (2018)
Monthly review: production, investment, finance
Romanova S.
PDF
(Rus)
No 11-12 (2020)
Agile stockpiles an insurance for drug supply
Gilissen E., Mulligan C., Tottman S., Troein P.
PDF
(Rus)
No 6 (2018)
Drug labelling: experience of implementation and prospects
Slinyakov Е.Е.
PDF
(Rus)
No 3 (2021)
Study of the availability of gene therapeutic drugs in the Russian Federation
Koshechkin K.A., Romanov P.A., Mokhov A.A., Khokhlov A.L.
PDF
(Rus)
No 4 (2021)
Building a logical-semantic model of the choice of fixed combinations of drugs for treatment of hypertension
Ibragimova G.Y., Fedotova A.A., Iksanova G.R., Khasanova R.Y., Vasilchenko K.A.
No 9 (2019)
Dementia drugs market analysis in Russia
Trofimova Е.О., Izvekov N.V.
PDF
(Rus)
No 11 (2018)
Road map and BAA market: forecasts and risks
Borzova M.
PDF
(Rus)
No 10 (2020)
Pharmaceutical industry in the first half of 2020
Romanova S.
PDF
(Rus)
No 5 (2018)
Investment activity of pharmaceutical enterprises: 9 months of 2017
Romanova S.
PDF
(Rus)
No 3 (2021)
A structural analysis of sales of drugs for the treatment of chronic hepatitis C in the Russian market
Tsitlionok E.A., Narkevich I.A., Nemyatykh O.D., Siukaeva D.D., Grinyuk A.S., Lisachenko V.O.
PDF
(Rus)
No 13S (2018)
Main trends in the Moscow labor market in medicine and pharmaceutics in 2017
Ignatova M.
PDF
(Rus)
No 9 (2019)
Development of the rare (orphan) drug market
Yurochkin D.S., Golant Z.M., Narkevich I.A.
PDF
(Rus)
No 10 (2018)
Monthly review: production, investment, finance
Romanova S.
PDF
(Rus)
No 10 (2020)
AnviMax®: optimal drug to combat ARVI and influenza
Kalinina N.
PDF
(Rus)
No 5 (2018)
Russian pharmaceutical market at the first quarter-end 2018
Denisova M., Prozerina J.
PDF
(Rus)
No 1 (2021)
Investment activity of pharmaceutical enterprises:intermediate results for 2020
Romanova S.
PDF
(Rus)
No 13S (2018)
Top drugs of the Russian pharmaceutical market in 2017
Article E.
PDF
(Rus)
No 7-8 (2019)
Priority needs in creating restricted drug lists in Russia. Feasible approach
Kolbin A.S., Maksimkina E.A., Mishinova S.A.
PDF
(Rus)
No 10 (2018)
Regulatory aspects of the introduction of the drug therapy outcomes-based payment concept
Tolkushin A.G., Fedorov A.A., Yagudina R.I., Davydovskaya M.V., Chernitskaya M.K., Ermolaeva T.N., Kobzeva N.V., Kokushkin K.A.
PDF
(Rus)
No 10 (2020)
Pharmacy market for 9 months 2020: coronavirus and digital
Kalinina N.
PDF
(Rus)
No 3 (2022)
Analysis of the budget expenditure for rare diseases in the subjects of the Russian Federation
Komarov I.A., Krasilnikova E.Y., Aleksandrova O.Y.
PDF
(Rus)
No 5 (2018)
Analysis of development trends of the pharmaceutical market of non-steroidal anti-inflammatory drugs in Russia
Oleynikova T.A., Pozhidaeva D.N.
PDF
(Rus)
No 1 (2021)
New old trends. Advertising practice
Borzova M.
PDF
(Rus)
No 13S (2018)
Analysis of the FFP Tender Market in 2017
Article E.
PDF
(Rus)
No 7-8 (2019)
Exclusive rights protection practice in the pharmaceutical sector and trends of its development
Borzova M.
PDF
(Rus)
No 10 (2018)
New immunization level
Shirokova I.
PDF
(Rus)
No 10 (2020)
Innovative medicines on the Russian pharmaceutical market:key players and main directions of development
Chaplenko A.A., Vlasov V.V., Gildeeva G.N.
PDF
(Rus)
No 2 (2022)
“New” rare diseases and budget deficiency: is the problem “great”?
Komarov I.A., Krasilnikova E.Y., Aleksandrova O.Y.
PDF
(Rus)
No 4 (2018)
Risk sharing schemes based on cost-effectiveness of multiple sclerosis disease modifying drugs: foreign experience and the possibilities of its use in Russia
Tolkushin A.G., Kholovnya-Voloskova M.E., Andreev D.A., Khachanova N.V., Ermolaeva T.N., Davydovskaya M.V., Kokushkin K.A.
PDF
(Rus)
No 1 (2021)
Management by objectives method in the government support arrangements for the public pharmacare system
Tarabukina S.M., Dremova N.B.
PDF
(Rus)
No 13S (2018)
Russian pharmaceutical market: results and forecasts
Article E.
PDF
(Rus)
No 5 (2019)
Methodical approaches to the development of the structural-logical scheme of personalized therapeutic drug management for cancer patients
Tarabukina S.M., Moshkova L.V., Chertovskikh Y.V.
PDF
(Rus)
No 10 (2018)
The role of modern herbal remedies in the management of cough
Prozherina J.
PDF
(Rus)
No 9 (2020)
Investment activity of pharmaceutical enterprises: 2019
Romanova S.
PDF
(Rus)
No 2 (2022)
Marketing analysis of the range of medicines for physiotherapy
Shubina K.A., Shakirova D.H.
PDF
(Rus)
No 3 (2018)
Key trends of the antiparkinsonian drugs market
Prozherina J.
PDF
(Rus)
No 1 (2021)
In combat against viruses
Shirokova I., Prozherina Y.
PDF
(Rus)
No 12 (2018)
Monthly review: production, investment, finance
Romanova S.
PDF
(Rus)
No 5 (2019)
Nomenclature of gene-therapy drugs: international experience
Mokhov A.A., Merkulov V.A., Melnikova E.V., Popov P.I., Dudchenko V.V., Koshechkin К.А., Chaplenko A.A., Yavorsky A.N.
PDF
(Rus)
No 9 (2018)
Monthly review: production, investment, finance
Romanova S.
PDF
(Rus)
No 9 (2020)
Symptomatic Slow-Acting Drugs (SYSADOA) is the new reality in the treatment of osteoarthritis
Prozherina Y.
PDF
(Rus)
No 1 (2022)
Rare diseases in the subjects of the Russian Federation: are these patients rare?
Komarov I.A., Krasilnikova E.Y., Aleksandrova O.Y.
No 12 (2019)
If you can’t breathe through your nose
Kalinina N.
PDF
(Rus)
No 2 (2021)
Pharmaceutical industry for 2020
Romanova S.
PDF
(Rus)
No 12 (2018)
Gender peculiarities of the consumer behavior in the gastroenterological drugs market
Ermolaeva A.D., Lobutev L.A., Krivosheev S.A.
PDF
(Rus)
No 4 (2019)
ANALYSIS OF PATENT PORTFOLIOS IN THE ANTI-INFLUENZA DRUG SEGMENT
Vyukhin M., Rodnin A., Shulgin V.
PDF
(Rus)
No 7-8 (2018)
Conceptual issues of the federal state supervision reform in the sphere of circulation of drugs
Shevyrev D.N.
PDF
(Rus)
No 9 (2020)
Trend in global pharmaceutical market: COVID
Prozherina Y.
PDF
(Rus)
No 1 (2022)
Application of the ATC/DDD methodology in predicting the need for genetically engineered biological products used to treat patients with rheumatic diseases in a hospital setting
Ugoltsova V.N., Shakirova D.K., Abdulganieva D.I., Safiullin R.S.
No 12 (2019)
Advertising of prescription drugs: when you can’t have everything and even more
Borzova M.
PDF
(Rus)
No 2 (2021)
Preparing a proposal on entering a drug in the VED list: highlights
Tolkushin A.G., Kholovnya-Voloskova M.E., Pogudina N.L.
PDF
(Rus)
1 - 69 of 69 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

Mailing Address

Address: 105064, Moscow, st. Vorontsovo Pole, 12, building 1

Email: redactor@remedium-journal.ru

Phone: +7(495) 917-48-86



Principal Contact

Sherstneva Elena Vladimirovna
EXECUTIVE SECRETARY
FSSBI «N.A. Semashko National Research Institute of Public Health»

105064, Vorontsovo Pole st., 12, Moscow


Email: redactor@remedium-journal.ru

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies